News
Sanofi is buying U.K. biotechnology company Vicebio for up to $1.6 billion in a deal that seeks to strengthen the French drugmaker's portfolio of respiratory vaccines and leave pipeline setbacks ...
The deal seeks to strengthen the drugmaker’s portfolio of respiratory vaccines and help it move on from pipeline setbacks.
Andrew Lo asked ChatGPT for its opinion on Moderna Inc., a biotech stock that soared during the pandemic era. The advice: ...
Tom Romary's bold plan for BizTrip.Ai is to make the travel search bar obsolete, a phenomenon that is gaining ground beyond ...
Moderna director of travel, meetings and fleet Jennifer Steinke is training a new employee, and her name is TAMI. It stands for "Travel And Meetings Intelligence," and maybe, just maybe, one day at ...
“Coffee filters, unlike paper towels don't contain lint, so they make a great option for cleaning windows, mirrors, and ...
Explore more
The two companies collaborated on research showing quantum computing could greatly aid the design of mRNA-based medicines and ...
Moderna, already in cash-saving mode amid uncertain vaccine dynamics, is backing off from its plans to construct an mRNA drug ...
Moderna (MRNA) stock in focus as the company cancels plans for an mRNA manufacturing plant in Japan amid a challenging ...
Moderna said on Friday it is cancelling plans to build a messenger RNA manufacturing plant in Japan due to "changes in the ...
IBM and Moderna released research on Thursday advancing the use of quantum computing in the development of mRNA medicines, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results